|
CYCS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95032878735901E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02007291502559E-12 |
| Normal-vs-Stage2 |
3.474200E-01 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.081000E-03 |
| Stage1-vs-Stage3 |
7.684000E-02 |
| Stage1-vs-Stage4 |
4.70090000004308E-06 |
| Stage2-vs-Stage3 |
2.758900E-04 |
| Stage2-vs-Stage4 |
4.95109999998355E-06 |
| Stage3-vs-Stage4 |
2.606200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.08539996171942E-09 |
| Normal-vs-Asian |
3.85202980623944E-12 |
| Caucasian-vs-AfricanAmerican |
7.082000E-01 |
| Caucasian-vs-Asian |
6.985600E-01 |
| AfricanAmerican-vs-Asian |
9.430000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.43369760507994E-11 |
| Normal-vs-Female |
3.4449110231094E-12 |
| Male-vs-Female |
5.256600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.58404408981505E-12 |
| Normal-vs-Age(41-60Yrs) |
9.3780538890087E-13 |
| Normal-vs-Age(61-80Yrs) |
1.85269999997129E-06 |
| Normal-vs-Age(81-100Yrs) |
1.042980E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.066400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.616500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.086400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.025800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.895800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.790800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.005900E-04 |
| Classical-VS-Follicular |
4.30619999658433E-08 |
| Classical-VS-Other |
7.456000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
6.2360006047868E-11 |
| Tall-VS-Other |
1.958810E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
6.2961000000028E-05 |
| Follicular-VS-Normal |
2.903400E-01 |
| Other-VS-Normal |
3.95499999999993E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.78600040207289E-10 |
| Normal-vs-N1 |
1.62458935193399E-12 |
| N0-vs-N1 |
5.43790000029354E-07 |
|
|
